Updates are available Correction dated 2024-06-04
Click to view Correction: https://doi.org/10.1186/s40478-024-01795-y
-
Authors
Stopschinski, Barbara E.
Del Tredici, Kelly http://orcid.org/0000-0002-9130-7838
Estill-Terpack, Sandi-Jo
Ghebremedhin, Estifanos
Yu, Fang F.
Braak, Heiko http://orcid.org/0000-0002-6776-1045
Diamond, Marc I. http://orcid.org/0000-0002-8085-7770
-
Funding
Funding for this research was provided by:
aging minds foundation
cure alzheimer's foundation
berry cox foundation
chan-zuckerberg initiative
national institutes of health (RF1AG059689)
hans & ilse breuer foundation
king foundation
- License Information
-
More Information
Article History
Received: 3 September 2021
Accepted: 3 September 2021
First Online: 11 October 2021
Change Date: 4 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40478-024-01795-y
Declarations
:
: All animal maintenance and experiments adhered to the animal care and use protocols of the University of Texas Southwestern Medical Center. The autopsy brains used for this study were obtained in compliance with Ulm University ethics committee guidelines as well as German federal and state law governing human tissue usage.
: Not applicable.
: MID is co-developer of an anti-tau antibody currently in clinical trials (C2N 8E12 [NCT02494024]). The remaining authors declare that they have no competing interests.
